Tag: oncology

Targeted intraoperative radiation slashes pancreatic cancer recurrence to 5%

Editor's Note A Johns Hopkins team is reporting unprecedented success in preventing pancreatic cancer recurrence by combining pre-surgical and intraoperative radiation focused on a key anatomical area near the pancreas, News Medical Life Sciences October 30 reports. Citing a Johns Hopkins Medicine preliminary study, this approach reportedly reduced recurrence around…

Read More

By: Tarsilla Moura
November 5, 2025
Share

Remote monitoring speeds recovery, lowers complications after cancer surgery

Editor's Note Remote perioperative monitoring (RPM) accelerates recovery and reduces complications following major cancer surgery, according to a randomized trial published on August 28 by npj Digital Medicine and co-authored by researchers at the University of Miami Miller School of Medicine. The study enrolled 293 patients undergoing major abdominal or…

Read More

By: Tarsilla Moura
September 25, 2025
Share

Robotic surgery boosts 3-year relapse-free survival in rectal cancer

Editor's Note Robotic surgery improves 3-year relapse-free survival compared with laparoscopic surgery for rectal cancer, according to findings presented at the 2025 annual meeting of the Society of American Gastrointestinal and Endoscopic Surgeons, published by Gastroenterology & Endoscopy News on August 18. As detailed in the article, researchers conducted a…

Read More

By: Tarsilla Moura
August 28, 2025
Share

UC Davis secures $2M to study bone health in prostate cancer, prevent post-injury arthritis

Editor's Note The UC Davis Department of Orthopaedic Surgery has received more than $2.2 million in Department of Defense funding for two research projects addressing bone health in prostate cancer and preventing arthritis after joint injuries, a UC Davis Health July 15 news release reports. The larger grant, $1.8 million,…

Read More

By: Tarsilla Moura
August 20, 2025
Share

Pembrolizumab sets new standard in advanced head and neck cancer surgery, trial shows

Editor's Note According to results from a randomized trial, titled KEYNOTE-689, adding pembrolizumab (Keytruda) to surgery and standard adjuvant therapy significantly prolongs event-free survival (EFS) in patients with resectable, locally advanced head and neck squamous cell carcinoma (HNSCC), MedPage Today April 28 reports. Experts are calling the findings a major…

Read More

By: Tarsilla Moura
April 29, 2025
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat